Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Prepaid Assets (2020 - 2025)

Mereo BioPharma (MREO) has disclosed Prepaid Assets for 6 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 16.37% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, up 16.37% year-over-year, with the annual reading at $2.5 million for FY2025, 16.37% up from the prior year.
  • Prepaid Assets for Q4 2025 was $2.5 million at Mereo BioPharma, down from $2.7 million in the prior quarter.
  • The five-year high for Prepaid Assets was $5.4 million in Q4 2022, with the low at $555000.0 in Q2 2024.
  • Average Prepaid Assets over 5 years is $3.1 million, with a median of $2.7 million recorded in 2025.
  • The sharpest move saw Prepaid Assets crashed 57.82% in 2024, then skyrocketed 358.56% in 2025.
  • Over 5 years, Prepaid Assets stood at $3.8 million in 2021, then soared by 44.34% to $5.4 million in 2022, then decreased by 5.33% to $5.2 million in 2023, then plummeted by 57.82% to $2.2 million in 2024, then increased by 16.37% to $2.5 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $2.5 million, $2.7 million, and $2.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.